Cargando…
Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis
BACKGROUND: There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Therefore; this systematic review intended to provide the pooled seroprevalence of HE...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567642/ https://www.ncbi.nlm.nih.gov/pubmed/31195988 http://dx.doi.org/10.1186/s12879-019-4125-x |
_version_ | 1783427122941919232 |
---|---|
author | Dagnew, Mulat Belachew, Amare Tiruneh, Moges Moges, Feleke |
author_facet | Dagnew, Mulat Belachew, Amare Tiruneh, Moges Moges, Feleke |
author_sort | Dagnew, Mulat |
collection | PubMed |
description | BACKGROUND: There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Therefore; this systematic review intended to provide the pooled seroprevalence of HEV among pregnant women in Africa. METHODS: We searched, Pub Med, Science direct, African online journals and Google scholar electronic data bases and all available references until August 30, 2018. We included cross sectional studies and cohort studies. The search was further limited studies done in African pregnant women. Statistical analysis done by using Stata (version 11) software. The overall pooled prevalence of HEV presented by using the forest plot with 95% CI. The methodological qualities of included studies were assessed using Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instruments. RESULT: The pooled seroprevalence of HEV among pregnant women in Africa was 29.13% (95% CI 14.63–43.63). The highest seroprevalence was 84.3% in Egypt and the lowest 6.6% reported in Gabon. There was highest heterogeneity level where I(2) = 99.7%; P < 0.0001.The observed heterogeneity attributed to geographic location/ region, country, assay method used in each study and year of study published. Moreover, HEV seroprevalence varies between countries and within countries. The HEV infection among African pregnant women seems to have a decreasing trend over time. CONCLUSION: The seroprevalence of HEV among pregnant women in Africa is high. The seroprevalence of HEV among pregnant women differ with geographic location and assay method. Therefore, it is recommended to conduct further research on commercial ELISA kit sensitivity and specificity, molecular tests, incidence, morbidity and mortality and vertical transmission of HEV from mother to infant in Africa. TRIAL REGISTRATION: CRD42018084963. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4125-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6567642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-65676422019-06-27 Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis Dagnew, Mulat Belachew, Amare Tiruneh, Moges Moges, Feleke BMC Infect Dis Research Article BACKGROUND: There have been a number of studies about seroprevalence of HEV among pregnant women in Africa. However, the finding of seroprevalence of HEV infection among pregnant women is variable and inconsistent. Therefore; this systematic review intended to provide the pooled seroprevalence of HEV among pregnant women in Africa. METHODS: We searched, Pub Med, Science direct, African online journals and Google scholar electronic data bases and all available references until August 30, 2018. We included cross sectional studies and cohort studies. The search was further limited studies done in African pregnant women. Statistical analysis done by using Stata (version 11) software. The overall pooled prevalence of HEV presented by using the forest plot with 95% CI. The methodological qualities of included studies were assessed using Joanna Briggs Institute Meta-Analysis of Statistics Assessment and Review Instruments. RESULT: The pooled seroprevalence of HEV among pregnant women in Africa was 29.13% (95% CI 14.63–43.63). The highest seroprevalence was 84.3% in Egypt and the lowest 6.6% reported in Gabon. There was highest heterogeneity level where I(2) = 99.7%; P < 0.0001.The observed heterogeneity attributed to geographic location/ region, country, assay method used in each study and year of study published. Moreover, HEV seroprevalence varies between countries and within countries. The HEV infection among African pregnant women seems to have a decreasing trend over time. CONCLUSION: The seroprevalence of HEV among pregnant women in Africa is high. The seroprevalence of HEV among pregnant women differ with geographic location and assay method. Therefore, it is recommended to conduct further research on commercial ELISA kit sensitivity and specificity, molecular tests, incidence, morbidity and mortality and vertical transmission of HEV from mother to infant in Africa. TRIAL REGISTRATION: CRD42018084963. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12879-019-4125-x) contains supplementary material, which is available to authorized users. BioMed Central 2019-06-13 /pmc/articles/PMC6567642/ /pubmed/31195988 http://dx.doi.org/10.1186/s12879-019-4125-x Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Dagnew, Mulat Belachew, Amare Tiruneh, Moges Moges, Feleke Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
title | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
title_full | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
title_fullStr | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
title_full_unstemmed | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
title_short | Hepatitis E virus infection among pregnant women in Africa: systematic review and meta-analysis |
title_sort | hepatitis e virus infection among pregnant women in africa: systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567642/ https://www.ncbi.nlm.nih.gov/pubmed/31195988 http://dx.doi.org/10.1186/s12879-019-4125-x |
work_keys_str_mv | AT dagnewmulat hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis AT belachewamare hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis AT tirunehmoges hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis AT mogesfeleke hepatitisevirusinfectionamongpregnantwomeninafricasystematicreviewandmetaanalysis |